I agree that this site is using cookies. You can find further informations here.
X
Portale, Anthony A.
135  results:
Search for persons X
?
1

Burosumab vs conventional therapy in children with X-linked..:

Ward, Leanne M ; Högler, Wolfgang ; Glorieux, Francis H...
JBMR Plus.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Link..:

Imel, Erik A ; Glorieux, Francis H ; Whyte, Michael P...
The Journal of Clinical Endocrinology & Metabolism.  108 (2023)  11 - p. 2990-2998 , 2023
Link: https://doi.org/10.1210/..
 
?
3

Long-term Burosumab Administration Is Safe and Effective in..:

Weber, Thomas J ; Imel, Erik A ; Carpenter, Thomas O...
The Journal of Clinical Endocrinology & Metabolism.  108 (2022)  1 - p. 155-165 , 2022
Link: https://doi.org/10.1210/..
 
?
4

A review of ferric citrate clinical studies, and the ration..:

Hanudel, Mark R. ; Laster, Marciana L. ; Portale, Anthony A....
Pediatric Nephrology.  37 (2022)  11 - p. 2547-2557 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Efficacy of Burosumab in Adults with X-linked Hypophosphate..:

Brandi, Maria Luisa ; Jan de Beur, Suzanne ; Briot, Karine...
Calcified Tissue International.  111 (2022)  4 - p. 409-418 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Effect of Burosumab Compared With Conventional Therapy on Y..:

Ward, Leanne M ; Glorieux, Francis H ; Whyte, Michael P...
The Journal of Clinical Endocrinology & Metabolism.  107 (2022)  8 - p. e3241-e3253 , 2022
Link: https://doi.org/10.1210/..
 
?
7

OR13-2 Characterizing the Impact of Burosumab on Bone Healt..:

Carpenter, Thomas ; Cassinelli, Hamilton ; Glorieux, Francis...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A191-A192 , 2022
Link: https://doi.org/10.1210/..
 
?
8

Patient-Reported Outcomes from a Randomized, Active-Control..:

Padidela, Raja ; Whyte, Michael P. ; Glorieux, Francis H....
Calcified Tissue International.  108 (2021)  5 - p. 622-633 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Sustained Efficacy and Safety of Burosumab, a Monoclonal An..:

Linglart, Agnès ; Imel, Erik A ; Whyte, Michael P...
The Journal of Clinical Endocrinology & Metabolism.  107 (2021)  3 - p. 813-824 , 2021
Link: https://doi.org/10.1210/..
 
?
10

Burosumab treatment in adults with X-linked hypophosphataem..:

Briot, Karine ; Portale, Anthony A ; Brandi, Maria Luisa...
RMD Open.  7 (2021)  3 - p. e001714 , 2021
Link: https://doi.org/10.1136/..
 
?
11

OR29-01 Long-Term Safety in Adults with X-Linked Hypophosph..:

Insogna, Karl Leonard ; Rees, Linda ; Skrinar, Alison...
Journal of the Endocrine Society.  4 (2020)  Supplement_1 - p. , 2020
Link: https://doi.org/10.1210/..
 
?
12

Association Between Chronic Kidney Disease–Mineral Bone Dis..:

Yokoyama, Jennifer S. ; Matsuda-Abedini, Mina ; Denburg, Michelle R....
Kidney Medicine.  2 (2020)  4 - p. 398-406 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Long-term safety in adults with X-linked Hypophosphatemia (..:

Kamenický, Peter ; Portale, Anthony A. ; Carpenter, Tom...
Bone Reports.  13 (2020)  - p. 100654 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Continued Beneficial Effects of Burosumab in Adults with X-..:

Portale, Anthony A. ; Carpenter, Thomas O. ; Brandi, Maria Luisa...
Calcified Tissue International.  105 (2019)  3 - p. 271-284 , 2019
Link: https://doi.org/10.1007/..
 
?
15

OR13-2 Burosumab Resulted in Greater Improvement in Rickets..:

Imel, Erik ; Whyte, Michael ; Munns, Craig...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1210/..
 
1-15